0.86 CME

متلازمة التمثيل الغذائي وصحة القلب

المتحدث: الدكتورة راخي موريشوار تيربو

أستاذ، NKPSIMS، ناجبور

تسجيل الدخول للبدء

وصف

Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes. These conditions include high blood pressure, elevated blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels. When these risk factors occur together, they amplify the risk of developing cardiovascular issues. Metabolic syndrome is closely linked to insulin resistance, where the body struggles to use insulin effectively. Lifestyle changes, such as adopting a healthy diet, regular exercise, and weight management, are crucial in managing the syndrome. Early intervention is essential to prevent the progression to heart disease and other complications.

ملخص

  • Metabolic syndrome is a complex condition involving abdominal obesity, high blood pressure (over 130/80 mm Hg), impaired fasting glucose, insulin resistance, and elevated triglyceride levels. Diagnosis involves identifying at least three of these symptoms in a patient, although varying classification criteria exist. Clinical measures by organizations like WHO and the International Diabetes Federation emphasize these core symptoms for diagnosis.
  • The pathophysiology of metabolic syndrome, leading to cardiovascular disease, centers on insulin resistance, often caused by visceral adiposity. Visceral adiposity and insulin resistance are closely linked, leading to hyperinsulinemia, reduced insulin levels in the long term, and increased free fatty acid levels. This process contributes to chronic inflammation and activates neuro-humeral pathways, ultimately impacting cardiovascular health.
  • Insulin resistance reduces glucose uptake and utilization by the heart, potentially causing cardiac dysfunction. Visceral adiposity impairs insulin-mediated inhibition of lipolysis, raising free fatty acid levels in the body. This condition inhibits protein kinase activation in muscles, further elevating blood sugar, and promotes gluconeogenesis in the liver, exacerbating the diabetic state.
  • Visceral fat is metabolically active and synthesizes proteins such as plasminogen activator inhibitor, promoting a prothrombotic state. This, combined with inflammatory reactions and smooth muscle proliferation, leads to muscular remodeling and increased atherosclerosis. Additionally, neuro-humeral factors like leptin contribute to the syndrome by affecting energy homeostasis and activating the renin-angiotensin system, causing vascular damage through reactive oxygen species.
  • Risk factors for insulin resistance include genetic predisposition, obesity (especially visceral), physical inactivity, and a diet high in glycemic content, saturated fats, and processed foods. Certain medications like steroids, and hormonal disorders such as Cushing's syndrome and hypothyroidism, can also induce insulin resistance. Awareness of these factors is crucial for managing metabolic syndrome.
  • Management involves modifying controllable risk factors such as increasing physical activity (e.g., daily 45-minute walks), adopting a diet rich in fiber, vegetables, and fruits while limiting processed foods, and regularly monitoring blood glucose, blood pressure, and lipid levels. Medical interventions, including statins for lipid control, antihypertensives, and metformin for insulin resistance, are also essential.

تعليقات